These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 37927473)

  • 1. The Hippo pathway in endometrial cancer: a potential therapeutic target?
    Shen X; Li Q; Sun Y; Chen L; Xue F; Tian W; Wang Y
    Front Oncol; 2023; 13():1273345. PubMed ID: 37927473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor-Induced Activation of the PI3K Pathway.
    Wang C; Gu C; Jeong KJ; Zhang D; Guo W; Lu Y; Ju Z; Panupinthu N; Yang JY; Gagea MM; Ng PK; Zhang F; Mills GB
    Cancer Res; 2017 Apr; 77(7):1637-1648. PubMed ID: 28202507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological and pathological roles of the Hippo-YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis.
    Nishina H
    Cancer Sci; 2022 Jun; 113(6):1900-1908. PubMed ID: 35349740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HIPPO pathway in gynecological malignancies.
    Wang D; He J; Dong J; Meyer TF; Xu T
    Am J Cancer Res; 2020; 10(2):610-629. PubMed ID: 32195031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex roles of Hippo-YAP/TAZ signaling in hepatocellular carcinoma.
    Shi H; Zou Y; Zhong W; Li Z; Wang X; Yin Y; Li D; Liu Y; Li M
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):15311-15322. PubMed ID: 37608027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic Hippo signaling inhibits development of hepatocellular carcinoma.
    Liu Y; Wang X; Yang Y
    Clin Mol Hepatol; 2020 Oct; 26(4):742-750. PubMed ID: 32981290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs Regulating Hippo-YAP Signaling in Liver Cancer.
    Lee NH; Kim SJ; Hyun J
    Biomedicines; 2021 Mar; 9(4):. PubMed ID: 33808155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The regulatory mechanisms and functional roles of the Hippo signaling pathway in breast cancer.
    Yao CB; Zhou X; Chen CS; Lei QY
    Yi Chuan; 2017 Jul; 39(7):617-629. PubMed ID: 28757476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
    Juan WC; Hong W
    Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippo Signaling in Cancer: Lessons From
    Snigdha K; Gangwani KS; Lapalikar GV; Singh A; Kango-Singh M
    Front Cell Dev Biol; 2019; 7():85. PubMed ID: 31231648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arhgef7 promotes activation of the Hippo pathway core kinase Lats.
    Heidary Arash E; Song KM; Song S; Shiban A; Attisano L
    EMBO J; 2014 Dec; 33(24):2997-3011. PubMed ID: 25425573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway.
    Fujimoto D; Ueda Y; Hirono Y; Goi T; Yamaguchi A
    Oncotarget; 2015 Oct; 6(33):34788-99. PubMed ID: 26431277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the Hippo/TAZ pathway is required for menstrual stem cells to suppress myofibroblast and inhibit transforming growth factor β signaling in human endometrial stromal cells.
    Zhu H; Pan Y; Jiang Y; Li J; Zhang Y; Zhang S
    Hum Reprod; 2019 Apr; 34(4):635-645. PubMed ID: 30715393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway.
    Jang JW; Kim MK; Bae SC
    Small GTPases; 2020 Jul; 11(4):280-288. PubMed ID: 29457552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the Hippo pathway and mechanisms for controlling cellular localization of YAP/TAZ.
    Kwon H; Kim J; Jho EH
    FEBS J; 2022 Oct; 289(19):5798-5818. PubMed ID: 34173335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WW Domain-Containing Proteins YAP and TAZ in the Hippo Pathway as Key Regulators in Stemness Maintenance, Tissue Homeostasis, and Tumorigenesis.
    Chen YA; Lu CY; Cheng TY; Pan SH; Chen HF; Chang NS
    Front Oncol; 2019; 9():60. PubMed ID: 30805310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent insight into the role and therapeutic potential of YAP/TAZ in gastrointestinal cancers.
    Wang Y; Chen H; Yu J; Kang W; To KF
    Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188787. PubMed ID: 36041574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmembrane protein KIRREL1 regulates Hippo signaling via a feedback loop and represents a therapeutic target in YAP/TAZ-active cancers.
    Gu Y; Wang Y; Sha Z; He C; Zhu Y; Li J; Yu A; Zhong Z; Wang X; Sun Y; Lan F; Yu FX
    Cell Rep; 2022 Aug; 40(9):111296. PubMed ID: 36044856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Prolyl isomerase Pin1 as a novel positive regulator of YAP/TAZ in breast cancer cells.
    Khanal P; Yeung B; Zhao Y; Yang X
    Sci Rep; 2019 Apr; 9(1):6394. PubMed ID: 31015482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippo-Independent Regulation of Yki/Yap/Taz: A Non-canonical View.
    Cho YS; Jiang J
    Front Cell Dev Biol; 2021; 9():658481. PubMed ID: 33869224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.